Hollsteen
← Arm

Research and development

Flow – sum over the period · $M

$MResearch and development · FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · FY2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · FY2022: $995M · 20-F 0001973239-24-000012 filed May 29, 2024Research and development · FY2023: $1.1B · 20-F 0001973239-24-000012 filed May 29, 2024Research and development · FY2024: $2.0B · 20-F 0001973239-24-000012 filed May 29, 2024Research and development · FY2025: $2.1B · 20-F 0001973239-25-000016 filed May 28, 2025Research and development · FY2026: $2.8B · 20-F 0001973239-26-000097 filed May 26, 2026missing2,776995FY2016FY2026FY2021
$MResearch and development · FY2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · FY2022: $995M · 20-F 0001973239-24-000012 filed May 29, 2024Research and development · FY2023: $1.1B · 20-F 0001973239-24-000012 filed May 29, 2024Research and development · FY2024: $2.0B · 20-F 0001973239-24-000012 filed May 29, 2024Research and development · FY2025: $2.1B · 20-F 0001973239-25-000016 filed May 28, 2025Research and development · FY2026: $2.8B · 20-F 0001973239-26-000097 filed May 26, 20262,776995FY2021FY2026FY2024
FY2026
2,776$M
All values (5)
PeriodValue ($M)Status
FY20262,776reported
FY20252,071reported
FY20241,979reported
FY20231,133reported
FY2022995reported

6 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: rnd

More metrics for Arm

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Sources & calculation
Value
$2.8B
Period
FY2026, ended Mar 31, 2026 · fiscal-year value (12 months)
Source
20-F, filed May 26, 2026 · 0001973239-26-000097
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Basis
Währung: USD, wie im 20-F reported (US-GAAP). Keine USD-Umrechnung. Nur Jahreswerte.

Versions

v1$2.8BMay 26, 202620-F 0001973239-26-000097reported · confidence 1. · current